Additionally, tumor cell metabolism can shape the composition and functionality of immune cell populations by releasing factors such as transforming growth factor-beta (TGF-β) and interleukin-10 (IL-10), which suppress immune responses (31, 32). The gene discussed is TGFB1; the disease is neoplasm.